RU2002106874A - Pharmaceutical compositions for the treatment of psoriasis - Google Patents
Pharmaceutical compositions for the treatment of psoriasis Download PDFInfo
- Publication number
- RU2002106874A RU2002106874A RU2002106874/14A RU2002106874A RU2002106874A RU 2002106874 A RU2002106874 A RU 2002106874A RU 2002106874/14 A RU2002106874/14 A RU 2002106874/14A RU 2002106874 A RU2002106874 A RU 2002106874A RU 2002106874 A RU2002106874 A RU 2002106874A
- Authority
- RU
- Russia
- Prior art keywords
- dexrazoxane
- infusion
- hydrochloride
- injection
- terms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Claims (31)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT155899 | 1999-09-10 | ||
ATA1558/99 | 1999-09-10 | ||
US18380600P | 2000-02-22 | 2000-02-22 | |
US60/183,806 | 2000-02-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2002106874A true RU2002106874A (en) | 2003-11-20 |
Family
ID=25596169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002106874/14A RU2002106874A (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical compositions for the treatment of psoriasis |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1214073A2 (en) |
KR (1) | KR20020035131A (en) |
CN (1) | CN1378451A (en) |
AU (1) | AU7286500A (en) |
BG (1) | BG106428A (en) |
BR (1) | BR0013921A (en) |
CA (1) | CA2384685A1 (en) |
CZ (1) | CZ2002729A3 (en) |
EE (1) | EE04871B1 (en) |
HR (1) | HRPK20020201B1 (en) |
HU (1) | HUP0202791A3 (en) |
MX (1) | MXPA02002486A (en) |
PL (1) | PL354980A1 (en) |
RU (1) | RU2002106874A (en) |
SK (1) | SK2802002A3 (en) |
WO (1) | WO2001019358A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021053523A1 (en) * | 2019-09-18 | 2021-03-25 | Tryp Therapeutics | Compositions and methods to improve the therapeutic benefit of bis-dioxopiperazines |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1234935A (en) * | 1967-07-03 | 1971-06-09 | Nat Res Dev | Piperazine derivatives |
US3941790A (en) * | 1967-07-03 | 1976-03-02 | National Research Development Corporation | Bis diketopiperazines |
US4963679A (en) * | 1988-02-17 | 1990-10-16 | Erbamont, Inc. | Process for preparing bis (3,5-dioxopiperazinyl) alkanes or alkenes |
WO1995003054A1 (en) * | 1993-07-23 | 1995-02-02 | Lxr Biotechnology Inc. | Methods of treating apoptosis and associated conditions |
-
2000
- 2000-09-08 WO PCT/EP2000/008879 patent/WO2001019358A2/en not_active Application Discontinuation
- 2000-09-08 KR KR1020027003049A patent/KR20020035131A/en not_active Application Discontinuation
- 2000-09-08 AU AU72865/00A patent/AU7286500A/en not_active Abandoned
- 2000-09-08 RU RU2002106874/14A patent/RU2002106874A/en not_active Application Discontinuation
- 2000-09-08 PL PL00354980A patent/PL354980A1/en not_active Application Discontinuation
- 2000-09-08 BR BR0013921-1A patent/BR0013921A/en not_active Application Discontinuation
- 2000-09-08 SK SK280-2002A patent/SK2802002A3/en not_active Application Discontinuation
- 2000-09-08 HU HU0202791A patent/HUP0202791A3/en unknown
- 2000-09-08 EE EEP200200128A patent/EE04871B1/en not_active IP Right Cessation
- 2000-09-08 CZ CZ2002729A patent/CZ2002729A3/en unknown
- 2000-09-08 EP EP00960646A patent/EP1214073A2/en not_active Withdrawn
- 2000-09-08 CN CN00812682A patent/CN1378451A/en active Pending
- 2000-09-08 CA CA002384685A patent/CA2384685A1/en not_active Abandoned
- 2000-09-08 MX MXPA02002486A patent/MXPA02002486A/en unknown
-
2002
- 2002-02-22 BG BG106428A patent/BG106428A/en unknown
- 2002-03-05 HR HR20020201A patent/HRPK20020201B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EE200200128A (en) | 2003-04-15 |
HRP20020201A2 (en) | 2003-06-30 |
SK2802002A3 (en) | 2003-02-04 |
CZ2002729A3 (en) | 2002-07-17 |
HRPK20020201B1 (en) | 2004-08-31 |
BG106428A (en) | 2003-04-30 |
EP1214073A2 (en) | 2002-06-19 |
AU7286500A (en) | 2001-04-17 |
HUP0202791A3 (en) | 2003-02-28 |
CN1378451A (en) | 2002-11-06 |
MXPA02002486A (en) | 2004-09-10 |
HUP0202791A2 (en) | 2003-01-28 |
EE04871B1 (en) | 2007-08-15 |
WO2001019358A2 (en) | 2001-03-22 |
PL354980A1 (en) | 2004-03-22 |
BR0013921A (en) | 2002-05-14 |
KR20020035131A (en) | 2002-05-09 |
CA2384685A1 (en) | 2001-03-22 |
WO2001019358A3 (en) | 2001-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5185488B2 (en) | 2- (4-Isobutylphenyl) propionic acid pharmaceutical composition | |
DK2574167T3 (en) | LIQUID NOSE SPRAY CONTAINING low-dose naltrexone | |
US6727286B2 (en) | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid | |
AU2002224475A1 (en) | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid | |
AU2003240113B2 (en) | Formulation of nefopam and its use in the treatment of pain | |
US20040132823A1 (en) | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid | |
WO2014176417A1 (en) | Topical preparation for bypassing gi tract, delivery of therapeutics, and trans-epithelial drug delivery system | |
JPH08295637A (en) | Local administrative agent for oral cavity | |
FI105075B (en) | Use of combination injection product | |
RU2002106874A (en) | Pharmaceutical compositions for the treatment of psoriasis | |
WO2005060957A1 (en) | Formulation of nefopam and its use in the treatment of pain | |
JP3253878B2 (en) | Formulations for iron chelation, methods of preparing the same and methods of treating Mediterranean anemia | |
US6693100B1 (en) | Pharmaceutical compositions for treating psoriasis | |
TW536400B (en) | Pharmaceutical composition for the treatment of immunodeficiency disease which cause by HIV infection | |
KR100379155B1 (en) | New analgesic composition | |
GB2321190A (en) | Medicament pack for treating Parkinson's Disease | |
JPS58164516A (en) | Remedy for eczematoid skin disease and drug rash | |
CN117243948A (en) | Application of daphnetin-containing composition in preparation of rheumatic arthritis drugs | |
JPS6345371B2 (en) | ||
WO2020172498A1 (en) | Naloxone formulations for sublingual and/or buccal administration | |
JPS61200917A (en) | Medicinal composition containing betaxolol and nifedipin | |
JPH0959149A (en) | Antiphlogistic and analgesic composition | |
RU2001128509A (en) | METHOD FOR TREATING NEURODEGENERATION | |
JPS61129127A (en) | Antitumor agent | |
JPS62120318A (en) | Remedy for prostatomegaly |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20000908 |